Co-Diagnostics, Inc. (CODX)

NASDAQ: CODX · IEX Real-Time Price · USD
1.120
+0.010 (0.90%)
At close: Mar 28, 2024, 4:00 PM
1.150
+0.030 (2.68%)
After-hours: Mar 28, 2024, 5:22 PM EDT

Total Valuation

Co-Diagnostics has a market cap or net worth of $34.70 million. The enterprise value is -$20.86 million.

Market Cap 34.70M
Enterprise Value -20.86M

Important Dates

The last earnings date was Thursday, March 14, 2024, after market close.

Earnings Date Mar 14, 2024
Ex-Dividend Date n/a

Share Statistics

Co-Diagnostics has 31.26 million shares outstanding. The number of shares has decreased by -6.77% in one year.

Shares Outstanding 31.26M
Shares Change (YoY) -6.77%
Shares Change (QoQ) +0.36%
Owned by Insiders (%) 2.68%
Owned by Institutions (%) 15.79%
Float 30.41M

Valuation Ratios

PE Ratio n/a
Forward PE 16.00
PS Ratio 5.09
Forward PS 5.87
PB Ratio 0.40
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.81, with a Debt / Equity ratio of 0.03.

Current Ratio 10.81
Quick Ratio 10.24
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -35.40% and return on invested capital (ROIC) is -47.98%.

Return on Equity (ROE) -35.40%
Return on Assets (ROA) -32.60%
Return on Capital (ROIC) -47.98%
Revenue Per Employee $43,949
Profits Per Employee -$227,954
Employee Count 155
Asset Turnover 0.06
Inventory Turnover 1.20

Taxes

Income Tax -2.78M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -19.42% in the last 52 weeks. The beta is -0.70, so Co-Diagnostics's price volatility has been lower than the market average.

Beta (1Y) -0.70
52-Week Price Change -19.42%
50-Day Moving Average 1.17
200-Day Moving Average 1.21
Relative Strength Index (RSI) 46.58
Average Volume (30 Days) 70,136

Short Selling Information

The latest short interest is 381,538, so 1.22% of the outstanding shares have been sold short.

Short Interest 381,538
Short Previous Month 341,333
Short % of Shares Out 1.22%
Short % of Float 1.25%
Short Ratio (days to cover) 6.76

Income Statement

In the last 12 months, Co-Diagnostics had revenue of $6.81 million and -$35.33 million in losses. Loss per share was -$1.20.

Revenue 6.81M
Gross Profit 2.63M
Operating Income -42.71M
Pretax Income -38.11M
Net Income -35.33M
EBITDA -36.83M
EBIT -38.11M
Loss Per Share -$1.20
Full Income Statement

Balance Sheet

The company has $58.55 million in cash and $2.99 million in debt, giving a net cash position of $55.56 million or $1.78 per share.

Cash & Cash Equivalents 58.55M
Total Debt 2.99M
Net Cash 55.56M
Net Cash Per Share $1.78
Equity / Book Value 86.01M
Book Value Per Share 2.75
Working Capital 56.39M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$22.08 million and capital expenditures -$1.37 million, giving a free cash flow of -$23.45 million.

Operating Cash Flow -22.08M
Capital Expenditures -1.37M
Free Cash Flow -23.45M
FCF Per Share -$0.80
Full Cash Flow Statement

Margins

Gross margin is 38.57%, with operating and profit margins of -626.92% and -518.68%.

Gross Margin 38.57%
Operating Margin -626.92%
Pretax Margin -559.46%
Profit Margin -518.68%
EBITDA Margin -540.69%
EBIT Margin -559.46%
FCF Margin -344.20%

Dividends & Yields

Co-Diagnostics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 6.77%
Shareholder Yield 6.77%
Earnings Yield -101.83%
FCF Yield -67.57%

Analyst Forecast

The average price target for Co-Diagnostics is $2.50, which is 123.21% higher than the current price. The consensus rating is "Hold".

Price Target $2.50
Price Target Difference 123.21%
Analyst Consensus Hold
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Co-Diagnostics has an Altman Z-Score of 1.77 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.77
Piotroski F-Score 2